Karyopharm Therapeutics competitors
Karyopharm Therapeutics's competitors include Affigen, Merrimack Pharmaceuticals, TESARO and AVEO Pharmaceuticals
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. |  TESARO TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. | |
Founding Date | Founding Date 2008 | Founding Date 2016 | Founding Date 2000 | Founding Date 2010 | Founding Date 2001 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Newton, US HQ München, DE | Locations St. Louis, US HQ | Locations Cambridge, US HQ | Locations Waltham, US HQ | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 8 | Employees 294 | Employees 446 | Employees 20 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 75.4 m | Valuation ($) 2.1 b | Valuation ($) 344 m |
Facebook likes | Facebook likes 126 | Facebook likes N/A | Facebook likes 647 | Facebook likes N/A | Facebook likes 445 |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 1.8 k | Twitter followers 650 |
Financial ⚠ | |||||
Net income | Net income ($109.6m) (FY, 2016) | Net income N/A | Net income $470.9m (FY, 2017) | Net income ($496.1m) (FY, 2017) | Net income ($26.9m) (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised $ 248.7m | Total funding raised $ 17m | Total funding raised $ 79.4m | Total funding raised $ 161m | Total funding raised $ 138.2m |
For sources of this data, please see the company profileDownload Excel
View company profiles
Affigen
HQ
St. Louis, US
Employees
8
Affigen develops tumor-identifying therapies to treat cancer.
View companyMerrimack Pharmaceuticals
HQ
Cambridge, US
Employees
294
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyTESARO
HQ
Waltham, US
Employees
446
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
View companyAVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View company